Navigation Links
Bioscience Company Chooses Microsoft Dynamics AX to Improve Support for Compliance With Industry Rules

PURE Bioscience picks Microsoft technology over competitors for its ease of

use, scalability and manufacturing capabilities.

REDMOND, Wash., March 25 /PRNewswire-FirstCall/ -- Microsoft Corp. today announced that PURE Bioscience has selected Microsoft Dynamics AX 4.0 to speed and integrate its business processes, helping to support the company's compliance with the Sarbanes-Oxley Act and with the requirements of numerous regulatory authorities, including the Food and Drug Administration (FDA) and Environmental Protection Agency (EPA) in the United States. Microsoft Dynamics AX is a comprehensive business-management solution for midsize and larger organizations that offers a high degree of scalability, customizability and full industry-specific functionality. It helps optimize and centralize supply chain processes and improves real-time visibility into operations.


PURE Bioscience, headquartered in El Cajon, Calif., develops and markets technology-based bioscience products that provide nontoxic solutions to numerous global health challenges. As a public company, PURE needed to remain compliant with Section 404 of the Sarbanes-Oxley Act. It also sought a way to produce its financials more rapidly because its growth would move the company into the category of an accelerated Securities and Exchange Commission (SEC) filer during 2008.

PURE had been relying significantly on legacy systems and spreadsheets for financial operations, but management saw a need to both integrate its data and find advanced technology for automating its processes to help manage the significant growth and increased complexity that the company anticipated.

The company evaluated a number of enterprise resource planning solutions to support its manufacturing and financial requirements, including FourthShift Edition for SAP Business One, before selecting Microsoft Dynamics AX 4.0.

"We chose Microsoft Dynamics AX 4.0 for multiple reasons," said Michael L. Krall, CEO of PURE Bioscience, "including ease of use, the Microsoft look and feel that employees are accustomed to, the ability for the company to grow with the solution, the ability of the solution to handle process manufacturing, favorable scalable pricing for a medium-sized business, well- defined validation methodologies, speed to go live, and the ability to continue to meet our SEC reporting obligations as we transition out of the small-business reporting category."

Working with PURE, Microsoft Gold Certified Partner Advanced Systems Integration Inc. of Lake Forest, Calif., will implement Microsoft Dynamics AX 4.0 Advanced Management Edition with additional source code that allows customization of proprietary processes and procedures that could not be met by any other solution.

"The ability to purchase and add modules, such as Production II or Shop Floor Control, in the future as we grow played an important part in our decision," Krall said. "The new system will be integrated seamlessly with other Microsoft products that PURE has been using, including the 2007 Microsoft Office system, Windows XP Professional, SQL Server 2005 and Windows Server 2003 R2 Enterprise Edition."

"We expect Microsoft Dynamics AX 4.0 to enhance our ability to manage the anticipated growth in our bioscience technology across multiple industries and applications, both within the United States and internationally," said Andrew J. Buckland, CFO at PURE Bioscience.

PURE Bioscience foresees the following benefits from its implementation of Microsoft Dynamics AX 4.0:
-- Support for growth. One of the primary objectives of the

implementation is to provide PURE with a technology that will allow

for management of considerable growth.

-- Industry-specific requirements. In addition to financial-related

regulatory compliance, Microsoft Dynamics AX 4.0 will support

processes that enable PURE to meet regulatory reporting obligations to

the U.S. EPA and to maintain its FDA Current Good Manufacturing

Practices certification for the production of active pharmaceutical

ingredients. Microsoft Dynamics AX 4.0 ensures data integrity and

transparency using security features while reporting variances and

communicating material events.

-- Improved reporting. Microsoft Dynamics AX 4.0 will enable the company

to produce statutory accounting and management information more

rapidly than before, helping it to remain compliant with regulatory

reporting while allowing management to make business decisions that

are more timely and effective.

-- Time savings. Microsoft Dynamics AX 4.0 will significantly shrink the

time needed to produce financial reports, supporting the company's

needs for faster reporting as it becomes an accelerated SEC filer.

-- Accuracy of data. Instead of relying on spreadsheets and multiple

systems and processes, PURE will take advantage of the Microsoft

Dynamics AX 4.0 capability to integrate many routines into one,

eliminating repetitive data entry and thereby increasing accuracy.

-- Better planning. Both business planning and resources planning are

expected to improve with PURE's new Microsoft technology.

-- More efficient supply chain management. Previously, supply chain

management was largely a manual process for PURE. Now it will be

automated to a large extent, providing the company with the capability

to support the larger and more complex manufacturing processes that it


"PURE Bioscience is realizing the value that Microsoft Dynamics AX brings to businesses in helping them meet the specific needs of their own industries," said Michael Park, corporate vice president for U.S. Dynamics Business at Microsoft. "As the manufacturing and regulatory environments become more complex, Microsoft technology is simplifying and integrating processes to enable businesses to accelerate their growth and fully employ their competitive advantages, while helping to ensure they remain compliant with government and industry regulations."

About PURE Bioscience

PURE Bioscience (PURE) develops and markets technology-based bioscience products that provide non-toxic solutions to numerous global health challenges. Its proprietary high- efficacy/low toxicity bioscience technologies represent innovative advances in diverse markets and lead today's global trend toward use of "green" products while providing competitive advantages in efficacy and safety.

About Advanced Systems Integration Inc.

Advanced Systems Integration, Inc. is a Gold Certified Microsoft Dynamics AX and Learning Solutions partner founded in 1991 that delivers comprehensive enterprise class applications that improve customer relations, enhance partner collaboration and create efficiencies across supply chains and business operations. ASi also offers industry specific extensions integrated with Microsoft Dynamics AX solution.

About Microsoft Dynamics

Microsoft Dynamics is a line of financial, customer relationship and supply-chain management solutions that helps businesses work more effectively. Delivered through a network of channel partners providing specialized services, these integrated, adaptable business management solutions work like and with familiar Microsoft software to streamline processes across an entire business.

About Microsoft

Founded in 1975, Microsoft (Nasdaq: MSFT) is the worldwide leader in software, services and solutions that help people and businesses realize their full potential.

SOURCE Microsoft Corp.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

2. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
3. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
4. Ohio Ranks Best in the Midwest for Venture Capital Investment in Health Care Bioscience Industry
6. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
8. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
9. Todd R. Nelson Named Chief Executive Officer of eBioscience, Inc.
10. Magellan Biosciences Names Steven E. Diamond, PhD, Chief Scientific Officer
11. Pressure BioSciences, Inc. Issued First Patent in Canada
Post Your Comments:
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
(Date:10/10/2017)... ... 2017 , ... San Diego-based team building and cooking events company, Lajollacooks4u, has ... The bold new look is part of a transformation to increase awareness, appeal to ... period. , It will also expand its service offering from its signature gourmet cooking ...
(Date:10/10/2017)... 10, 2017 International research firm Parks Associates announced ... at the TMA 2017 Annual Meeting , October 11 in ... residential home security market and how smart safety and security products impact ... Parks Associates: Smart Home ... "The residential security market has ...
(Date:10/9/2017)... DIEGO , Oct. 9, 2017  BioTech ... biological mechanism by which its ProCell stem cell ... critical limb ischemia.  The Company, demonstrated that treatment ... amount of limbs saved as compared to standard ... the molecule HGF resulted in reduction of therapeutic ...
Breaking Biology Technology:
(Date:3/28/2017)... , March 28, 2017 The ... Hardware (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, ... Region - Global Forecast to 2022", published by MarketsandMarkets, ... 2016 and is projected to reach USD 75.64 Billion ... and 2022. The base year considered for the study ...
(Date:3/24/2017)... 24, 2017 The Controller General of Immigration from ... Abdulla Algeen have received the prestigious international IAIR Award for the ... Continue Reading ... ... Controller Abdulla Algeen (small picture on the right) have received the IAIR ...
(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by Technology (Touch-based ... to 2022", published by MarketsandMarkets, the market is expected to be worth USD ... 2022. Continue Reading ... ... ...
Breaking Biology News(10 mins):